Literature DB >> 14668050

Growth factors in proliferative diabetic retinopathy.

Zia Ali Khan1, Subrata Chakrabarti.   

Abstract

Many growth factors are implicated in the pathogenesis of proliferative diabetic retinopathy. Alteration of growth factors and their receptors in diabetes has been shown in both experimental and clinical studies. Sustained hyperglycemia resulting from long-standing diabetes leads to several biochemical abnormalities that consequently result in retinal hypoxia. Retinal oxygenation state regulates various growth factors that promote angiogenesis in order to meet the oxygen demands of the tissue. However, unregulated expression of these growth factors and induction of complex cascades leading to augmentation of other proangiogenic factors, which may not be regulated by tissue oxygenation, leads to uncontrolled retinal neovascularization and blindness in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668050      PMCID: PMC2478606          DOI: 10.1155/EDR.2003.287

Source DB:  PubMed          Journal:  Exp Diabesity Res        ISSN: 1543-8600


  25 in total

1.  The outcomes of pars plana vitrectomy without endotamponade for tractional retinal detachment secondary to proliferative diabetic retinopathy.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

Review 2.  Antisense oligonucleotide therapy in diabetic retinopathy.

Authors:  Peter Hnik; David S Boyer; Lisa R Grillone; John G Clement; Scott P Henry; Ellen A Green
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  miR-195 regulates SIRT1-mediated changes in diabetic retinopathy.

Authors:  Rokhsana Mortuza; Biao Feng; Subrata Chakrabarti
Journal:  Diabetologia       Date:  2014-02-26       Impact factor: 10.122

4.  The Outcomes of Pars Plana Vitrectomy without Tamponade for Tractional Retinal Detachment Secondary to Diabetic Retinopathy.

Authors:  Rao Muhammad Rashad Qamar; Muhammad Imran Saleem; Muhammad Farhan Saleem
Journal:  Malays J Med Sci       Date:  2013-05

5.  The chemotactic activity of beta-carotene in endothelial cell progenitors and human umbilical vein endothelial cells: A microarray analysis.

Authors:  Anna Polus; Beata Kiec-Wilk; Jadwiga Hartwich; Adriana Balwierz; Jerzy Stachura; Grzegorz Dyduch; Piotr Laidler; Jacek Zagajewski; Thomas Langman; Gerd Schmitz; Regina Goralczyk; Karin Wertz; George Riss; Jaap Keijer; Aldona Dembinska-Kiec
Journal:  Exp Clin Cardiol       Date:  2006

6.  Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.

Authors:  Olga Gealekman; Alison Burkart; My Chouinard; Sarah M Nicoloro; Juerg Straubhaar; Silvia Corvera
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-26       Impact factor: 4.310

7.  Comparative investigation of kidney mesangial cells from increased oxidative stress-induced diabetic rats by using different microscopy techniques.

Authors:  Ayse Kose Sargin; Belgin Can; Belma Turan
Journal:  Mol Cell Biochem       Date:  2013-12-29       Impact factor: 3.396

Review 8.  MicroRNAs as regulators of endothelial cell functions in cardiometabolic diseases.

Authors:  Elisa Araldi; Yajaira Suárez
Journal:  Biochim Biophys Acta       Date:  2016-01-26

Review 9.  Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.

Authors:  Emily C Keats; Zia A Khan
Journal:  Cardiovasc Diabetol       Date:  2012-04-23       Impact factor: 9.951

10.  Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes.

Authors:  Suman Kalyan Paine; Analabha Basu; Lakshmi Kanta Mondal; Aditi Sen; Subhadip Choudhuri; Imran Hussain Chowdhury; Avijit Saha; Gautam Bhadhuri; Ankur Mukherjee; Basudev Bhattacharya
Journal:  Mol Vis       Date:  2012-11-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.